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About the Global State of Tobacco Harm 
Reduction (GSTHR) project
Harm reduction is a range of pragmatic policies, regulations, and actions which either 
reduce health risks by providing safer forms of products or substances or encourage 
less risky behaviours. Tobacco harm reduction (THR), using safer nicotine products 
(SNP), offers new choices to millions of people worldwide who want to switch away 
from smoking or other dangerous forms of tobacco use, but have been unable to with 
the other options available.
Since 2018, the UK-based public health agency Knowledge•Action•Change (K•A•C) 
has produced two biennial reports examining progress in and barriers to tobacco harm 
reduction around the world:
No Fire, No Smoke: The Global State of Tobacco Harm Reduction 2018 and Burning 
Issues: The Global State of Tobacco Harm Reduction 2020. Executive summaries of 
both reports are available in multiple languages as well as Chinese translations of the 
full 2018 and 2020 editions.
In addition, K•A•C publishes shorter reports such as this, driven by the key principles 
of the GSTHR project. The first, Tobacco Harm Reduction and the Right to Health, was 
published in January 2020 and can be read in 13 languages. The second, Tobacco 
Harm Reduction: a Burning Issue for Asia was published in April 2021. All GSTHR 
publications and translations can be downloaded at the GSTHR website, 
https://gsthr.org.
The GSTHR website offers a significant resource for researchers of tobacco harm 
reduction and smoking. The site allows users to search, compare and build bespoke 
data visualisations using regularly updated tobacco harm reduction and smoking 
statistics for more than 200 countries and territories. There is also a wealth of 
downloadable charts and infographics free to use in presentations. 
Visit https://gsthr.org to find out more.
Terminology
A number of terms are used for THR products, including ‘reduced risk products’ and 
‘electronic nicotine delivery systems’ and ‘electronic non-nicotine delivery systems 
(ENDS and ENNDS – terms favoured by WHO). This report uses the term safer nicotine 
products (SNP) as a collective expression for nicotine vaping devices, heated tobacco 
products (HTP) and safer oral nicotine products such as Swedish-style pasteurised snus 
and non-tobacco nicotine pouches.
Unless quoting from documents, we do not use the term ‘e-cigarettes’ to describe 
nicotine vaping devices. The term is misleading for health professionals, politicians and 
the wider public, as it closely associates these new products with cigarettes. However, 
vaping devices do not burn tobacco and do not emit toxic smoke which harms 
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1.  Despite all the efforts of tobacco control, there are still 1.1 billion smokers 
worldwide and many hundreds of thousands of people who use other dangerous 
tobacco products. smoking causes eight million deaths a year with a projected 
billion lives lost by 2021. eighty per cent of smokers live in low and middle-income 
countries (LMIC). They bear the brunt of deaths and disease. 
2.  The WHO claims that its monitoring and evaluation tobacco control strategy 
MPOWER ‘protects’ or ‘covers’ 5.3 billion people from deaths and diseases caused 
by smoking. In reality, the bureaucratic and political processes of passing tobacco 
control legislation protect nobody unless there are the necessary financial 
resources to implement legislation, a particular problem in LMIC where resources 
are stretched.
3.  There is a substantial body of global independent evidence that safer nicotine 
products (snP) are significantly safer than any combustible and many types of oral 
tobacco products. 
4.  Many smokers will successfully quit smoking using cessation support or nicotine 
replacement therapies. For those who do not want to quit nicotine, switching to 
safer nicotine products offers a substantial potential public health benefit for adult 
smokers, their families, and bystanders, at little cost to governments. 
5.  The WHO and its NGO allies are still engaged in an historic battle against the 
tobacco industry despite the emergence of new technologies. The evidence shows 
these products are significantly less risky than combustible tobacco and have a 
role to play in harm reduction. 
6.  For the WHO and its NGO allies, the goal of tobacco control has shifted from 
protection against tobacco and smoking to protection against nicotine itself. 
Innovative non-combustible nicotine technology and supporting evidence has 
moved forwards; tobacco control policy is frozen in time.
7.  Public health is not served by discouraging adult smokers from switching to snP, 
nor by implementing overly restrictive regulations that stop existing consumers 
accessing safer nicotine products. the traditional tobacco industry is the only 
winner, as the endgame for combustible cigarettes will disappear yet further into 
the future.
8.  The ‘mission creep’ of international tobacco control from protection against tobacco 
smoke to a war on nicotine in all its forms is particularly egregious; the global 
campaign against SNP is funded by neo-colonial western philanthropic interests 
pursuing their own agenda. LMic, whose populations are most significantly 
impacted by smoking-related harms, stand to lose the most. 
9.  The Framework convention on tobacco control (Fctc) secretariat and its WhO 
accredited ngOs have undue and unhealthy influence over the deliberations 
before and during the Fctc conference of the Parties (cOP) meetings on 
international tobacco and nicotine policy, as well as on post-COP implementation 
and interpretations of the meeting’s decisions.
10. it is unacceptable that the cOP, as an international meeting of government 
officials ultimately funded by citizens’ taxes, should be shrouded in a secrecy 
comparable to the Un security council.
11. The Guidelines to Article 5.3 of the FCTC are over-interpreted. Article 5.3 itself 
reasonably states that governments need to be open and transparent in their 
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dealings with the tobacco industry. The Guidelines add detail to this. the intention 
of the FCTC was never to entirely close dialogue between public health and 
industry, let alone be the justification for the growing range of attacks and no-
platforming experienced by tobacco harm reduction advocates.
12. the refusal of the WhO and other agencies to endorse snP despite significant 
international evidence in favour of their role in smoking cessation suggests little 
concern for current adult smokers. Efforts are entirely focused on the acceptable 
political ground of prevention aimed at young people. 
13. international tobacco control must refocus on delivering tangible outcomes 
that reduce death and disease from smoking among adult smokers. A radical 
overhaul of the FCTC is unlikely, nor is it required. Much can be achieved through 
recalibration and shifts in how the Convention is implemented at a national level.  
14. Parties need to exercise their control of the Fctc, rather than leave it to the 
Secretariat to take leadership, and examine all options for widening the off-ramp 
from smoking. A Working Group on Tobacco Harm Reduction should be established. 
A primary aim would be to make a clear distinction between combustible and 
non-combustible safer nicotine products. The FCTC entered into force before SNP 
became widely available and it follows that there needs to be a greater focus on 
the harm reduction element contained in the Fctc. 
15. the MPOWer implementation strategy should be reconfigured to rectify the 
current deficits in international tobacco control policy. MPOWER should become 
EMPOWERED:  
16. thr has a complementary role to play in tobacco control and reducing cigarette 
consumption. Its potential can come to fruition if the international tobacco control 
community, led by the WHO, can disaggregate combustible from non-combustible 
tobacco products in its policy and legislative deliberations.
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1: still too many left behind: 
the context for the report
The ambition
The main policy engine driving the international effort to combat the smoking epidemic 
is the WHO Framework Convention on Tobacco Control (FCTC), which entered into 
force in 2005. This enabled the creation of the Conference of the Parties (COP), regular 
meetings which bring together delegations of government representatives who discuss 
the implementation of FCTC measures. 
‘Tobacco control’ is defined in Article 1d:
‘Tobacco control’ means a range of supply, demand and harm reduction strategies 
that aim to improve the health of a population by eliminating or reducing their 
consumption of tobacco products and exposure to tobacco smoke.” 1 
In terms of how tobacco control has been implemented since 2005, it is important to 
note that one of the stated objectives as agreed by all the Parties to the FCTC was to 
protect populations by reducing the harms caused by exposure to tobacco smoke. 
Whatever the intention, there is no differentiation made in the Articles in terms of risks 
of exposure to tobacco smoke between smokers or bystanders, so by the letter of the 
Convention, smokers are not excluded from this definition.
In 2007, the WHO launched a process and monitoring mechanism to implement the 
FCTC, known as MPOWER:
Smoking is the single greatest preventable cause of non-communicable disease (NCD). 
It is also the one risk factor common to the four main groups of NCD: cardiovascular 
disease, cancer, chronic lung disease and diabetes. Reducing tobacco smoking is 
therefore key to driving down the global incidence of deaths from NCD – an ambition 
both reflected in and quantified by the UN 2030 Agenda for Sustainable Development. 
Goal 3 of the Agenda is to “ensure healthy lives and promote well-being for all at all 
ages”, with a specific goal (3.4) of “reducing premature deaths from non-communicable 
diseases by one third by 2030”.2
1 The Framework Convention on Tobacco Control (2005): https://www.who.int/fctc/text_download/en/  
2 United Nations. Transforming our World: The 2030 Agenda for Sustainable Development. UN, 2015, p.20. https://sustaina-
bledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf 









In 1997, the Global Burden of Disease (GBD) report estimated that around three 
million people were dying annually from tobacco use and projected a sharp increase 
in the decades to come. This analysis was sadly correct. The figure had risen to five 
million by 2002 with a WHO projection of eight million by 2030.3 By 2021, the annual 
death toll already exceeded eight million, including those who died from exposure 
to secondhand smoke. In 2001, Professor Richard Peto, a leading expert on tobacco 
mortality, estimated a billion lives would be lost by the end of the century – a forecast 
which remains unchanged.4 And while there are many thousands of deaths from oral 
tobacco products, the Institute for Health Metrics and Evaluation (IHME) estimates that 
99.9 per cent of all tobacco-related deaths are caused by smoking.5
3 Mathers, C and Loncar, D. Updated projections of global mortality and burden of disease 2002-2030: sources, methods 
and results. WHO, 2005
4 Peto R and Lopez AD. Future worldwide health effects of current smoking patterns. In: Koop CE, et al. eds. Critical issues in 
global health. San Francisco: Wiley (Jossey-Bass), 2001: 154-61. 
5 Ritchie, Hannah and Roser, Max. ‘Smoking’. Our World In Data (updated 2021). https://ourworldindata.org/smoking




Discarded cigarette butts. 
Credit: Pawel Czerwinski on Unsplash
Reference: compilation of data from Institute for Health Metrics and Evaluation (IHME). (2019). Global Burden of Disease 
(GBD 2019). IHME, University of Washington. http://www.healthdata.org/gbd/2019 and estimation by Peto, R., & Lopez, A. D. 
(2001). Future worldwide health effects of current smoking patterns. (pp. 154–161). Jossey-Bass. https://espace.library.uq.edu.
au/view/UQ:114032
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Smoking prevalence and therefore smoking-related deaths have been falling in high-
income countries (HIC) for several decades, but population growth means that there 
are still 1.1 billion smokers worldwide. LMIC carry the burden of death and disease 
of smoking, amounting to around 50 per cent of all global smoking-related deaths.6 
However, data for LMIC may underestimate the scale of the losses. As the WHO states, 
“High-income countries have systems in place for collecting information on causes 
of death in the population. Many low- and middle-income countries do not have such 
systems, and the numbers of deaths from specific causes have to be estimated from 
incomplete data”.7
It is LMIC that also bear the brunt of NCD. Three-quarters of NCD deaths occur in 
LMIC, where health systems are often not resourced to offer timely and appropriate 
treatments.8
6 Tobacco Harm Reduction: A Burning Issue for Asia. London: Knowledge Action Change (2021), p.9. https://gsthr.org/
report/2021/burning-issue-for-asia/chapter-1 
7 The Global Health Observatory, WHO. Total NCD deaths (in thousands). https://www.who.int/data/gho/data/indicators/
indicator-details/GHO/gho-ghe-ncd-deaths-in-thousands  
8 Factsheet: Noncommunicable diseases, WHO. (2021). https://www.who.int/news-room/fact-sheets/detail/ 
noncommunicable-diseases 
A man smokes on the street in Karnakata, India. 
Credit: Vaisakh MV on Unsplash
Data source: WHO. (2019). WHO global report on trends in prevalence of tobacco use 2000–2025, third edition. World 
Health Organization. https://www.who.int/publications/i/item/who-global-report-on-trends-in-prevalence-of-tobacco-
-use-2000-2025-third-edition
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The failure of ambition
The WHO often lauds the success of MPOWER; the most recent report (2021) on 
its progress stated that 5.3 billion people were ‘covered’ by at least one MPOWER 
element to the ‘highest level of achievement’9. But the accolade of ‘coverage’ by ‘at 
least one MPOWER measure’ begins to look less impressive given that MPOWER was 
launched in 2007. This is further compounded when it is revealed that nearly 30 per 
cent of countries who have signed up to the FCTC have not enacted a single MPOWER 
element. And closer analysis shows that, of the 49 countries with no element in place, 
41 are LMIC.10 It should also be noted that ‘covered’ often means little more than the 
enactment of frequently unenforceable laws, especially in LMIC where resources are 
stretched.
 
Critically, most of the elements of MPOWER do not directly alleviate the death and 
disease caused by smoking. They are mainly legislative measures which, as it happens, 
are relatively cheap and easy to enact. What is much more expensive, especially for 
LMIC with fragile health systems and a need to focus on communicable diseases, is 
‘O – Offering help to smokers to quit’. And by its own admission, the WHO concedes 
that delivery on this element is the weakest, with 70 per cent of the global population 
having no access to comprehensive smoking cessation services. 
Even where countries’ policies are cited as ‘best practice’, the truth on the ground can 
be very different. India is the only LMIC listed by the WHO as being a best practice 
country in providing support services. Yet a study of the availability and affordability 
of nicotine replacement therapy and cessation medicines in the Indian state of Kerala 
revealed that no products were available in public health care facilities and were only 
available in some private pharmacies.11 The situation would be even more acute for the 
millions of tobacco consumers living in rural areas.     
The WHO asserts that the slow progress towards reducing smoking levels in poorer 
countries is because the introduction of strong tobacco control policies has been 
The WHO flag.
Source: Flickr
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9 WHO. WHO report on global tobacco epidemic: addressing new and emerging products 2021. WHO, 2021. 
https://www.who.int/teams/health-promotion/tobacco-control/global-tobacco-report-2021  
10 ibid.  
11 Sarma Smitha et al. (2017). Availability, Sales, and Affordability of Tobacco Cessation Medicines in Kerala, India. Circulation: 
Cardiovascular Quality and Outcomes, 10(11), e004108. https://doi.org/10.1161/CIRCOUTCOMES.117.004108 
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impeded by lobbying from the tobacco industry. Lobbying may well be an issue, but 
this explanation alone fails to acknowledge the significant problems that accrue from 
the unwillingness of countries to fund internationally recognised tobacco control 
measures, at least since the financial crash of 2007-08 and even more so in an era of 
COVID. 
There also remain the enduring conflicts of interest of many countries with a seat at 
the COP table that have substantial if not monopoly stakes in their domestic tobacco 
industries. There are 18 countries where the state owns 10 per cent or more of at least 
one tobacco company. The governments of China, Iraq, Iran, Lebanon, Syria, Thailand, 
Tunisia and Vietnam have a 100 per cent monopoly interest. All but two are signatories 
to the FCTC. The Chinese National Tobacco Corporation (CNTC) outperforms all other 
multinational tobacco companies with 44 per cent of the global cigarette market. India’s 
state-owned tobacco company ITC is in the top five behind CNTC, British American 
Tobacco (BAT), Philip Morris International (PMI) and the Japan Tobacco International 
(JTI) – and the Japanese government owns one-third of that business.12
On the wider issue of dealing with NCD, the picture is equally bleak. A WHO NCD 
report noted, “Country actions against NCDs are uneven at best. National investments 
remain woefully small and not enough funds are being mobilized internationally…There 
is no excuse for inaction as we have evidence-based solutions”. 13
A range of nicotine replacement products. 
Source: Google
12 Malan, D and Hamilton, B. Contradictions and conflicts: state ownership of tobacco companies and the WHO Framework 
Convention on Tobacco Control. Just Managing Consulting, 2020.  
13 WHO. Time to deliver: report of the WHO independent high-level commission on non-communicable diseases. WHO, 2018, 
p.4 https://apps.who.int/iris/handle/10665/272710   
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Fighting the last war?
What is going wrong? In essence, the WHO, compliant governments and medical 
agencies, NGO allies and funders are fighting the last war against the tobacco industry. 
There are many historical examples, from the 19th century through to the Vietnam War, 
where generals assumed the political and technological environment of the current 
conflict remained unchanged from the last. Invariably this played out with deadly 
results for those on the frontline – while the generals watched from a distance.
It is clear from the statistics that coming up with the same old strategies and tactics 
for reducing global smoking are not nearly enough to deliver on the public health 
imperative. To repeat the words of the WHO, “there is no excuse for inaction as we 
have evidence-based solutions”.  
The new approaches for the 21st century are grounded in the principle of tobacco harm 
reduction (THR), based on encouraging current smokers to switch to safer nicotine 
products (SNP). Delivery requires new strategies and new thinking. Instead, and for a 
variety of reasons, those with the responsibility to show global leadership in fighting 
the smoking problem are digging ever deeper trenches. 
Photograph showing British troops using a trench periscope and trench mirror to view no man’s land.
Source: National Library of Scotland
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tobacco: the background to 
the Framework convention 
on tobacco control 
The truth will out
In 1954, following early research suggesting a link between smoking and cancer, the 
major US tobacco companies issued ‘A Frank Statement to Cigarette Smokers’ denying 
that their products were dangerous and claiming they only had the best interests of 
their customers at heart.14 
 
This assertion was not seriously challenged until the early 1960s, when the UK Royal 
College of Physicians15 (1962) and the US Surgeon General16 (1964) both published 
Source: Wikimedia
14 Yach, D (2014). The origins, development, effects, and future of the WHO Framework Convention on Tobacco Control:  
a personal perspective. Lancet: 383, 1771-79. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62155-8/
fulltext 
15 The Royal College of Physicians. Smoking and health: a report of the Royal College of Physicians on smoking in relation 
to cancer of the lung and other diseases (1962). Available at:  https://www.rcplondon.ac.uk/projects/outputs/smoking-and-
health-1962
16 The US Surgeon General. Smoking and health: report of the advisory committee to the Surgeon General of the public 
health service (1964). Available at: https://profiles.nlm.nih.gov/spotlight/nn/catalog/nlm:nlmuid-101584932X202-doc
14 gsthr.org
reports on the harmful effects of smoking. The WHO adopted its first resolution 
on smoking in 1970. Over the next three decades, 154 countries introduced some 
domestic tobacco control measures. 
For most of the 20th century, smoking-related death and disease was largely an 
issue for HIC. The WHO regarded this as a problem for those countries to deal with 
domestically – not least because the WHO was focused on the range of deadly 
communicable diseases ravaging LMIC. But a changing global economic climate, as 
much as a growing public health imperative, highlighted the need for more concerted 
action at an international level. 
 
International action against 
a transnational industry
From 1970 to the late 1990s, the major US tobacco companies became more 
transnational in outlook. The globalisation of the tobacco industry was greatly assisted 
by the opening up of Eastern European markets following the collapse of communism, 
pressure on countries from the World Bank and International Monetary Fund to 
liberalise foreign investment laws and privatise state companies, and the expansion of 
free trade areas in Asia and Latin America.17
Over a near-thirty-year period, rather than exporting cigarettes to LMIC, the industry 
was therefore gradually establishing footholds outside the US. While the land devoted to 
tobacco growing in the US reduced by 50 per cent, it doubled in Malawi, Tanzania and 
also China, where the industry was and remains a state monopoly.18 Momentum began 
to build within public health circles, recognising that the growth of a transnational tobacco 
industry needed to be countered by a transnational agreement on tobacco control. 
From its inception in 1948, the WHO (under Article 19 of the WHO Constitution) had the 
constitutional authority to develop a legal instrument aimed at improving population 
health. The WHO had never acted on this. There was resistance within the WHO, 
whose officials – totally lacking in any experience of international treaty negotiations – 
The World Bank Headquarters in Washington, D.C. 
Credit: Victor Grigas on Wikimedia Commons
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18 Wipfli, H. The Global War on Tobacco: Mapping the world’s first public health treaty. John Hopkins Press, 2015, p.18.
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were of the view that an international treaty on tobacco control was too ambitious and 
would struggle to get agreement.19 
Even so, in 1994, at the Ninth World Conference on Tobacco and Health, a resolution 
was passed to take international legal action to combat the global smoking epidemic. 
By then, it was recognised that smoking was not just an issue for HIC. Two years later, 
the World Health Assembly formally agreed that the WHO should begin the process of 
formulating a Framework Convention on Tobacco Control (FCTC). 
Public health over economic interests
Three circumstances drove the process forward. First was the appointment of Dr Gro 
Brundtland as Director General of the WHO. She was a medical doctor who had been 
involved in tobacco control in her native Norway, where she had served three terms 
as Prime Minister. Brundtland had also held high office in the UN within the realm of 
sustainable development. She had the political experience lacking in the WHO which 
had suffered “years of dysfunction [and] desperately needed strong, clear, innovative 
leadership”.20 Brundtland appointed a transition team including Derek Yach, who had 
been Chair of the All-Africa Tobacco Control Conference and would go on to become 
the founding Director of the WHO’s Tobacco Free Initiative (TFI).
Second, the 1998 Tobacco Master Settlement Agreement in the USA demonstrated 
that, as powerful as it was, the tobacco industry could be legally held to account. 
The Settlement saw the industry forced to pay millions of dollars in ‘reparations’ to 
individual US states to head off huge quantities of time-consuming litigation. Moreover, 
the disclosure of reams of industry documentation revealed the depth of deceit and 
corruption in the service of profit.  
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Thirdly, the World Bank, whose pressure on countries to open up trading channels 
had indirectly assisted the development of a globalised tobacco industry, published 
a report in 1999. Entitled Curbing the Epidemic it “provided perhaps the single most 
important tool in preparation for the FCTC negotiations.”21 The report majored on 
using demand reduction strategies such as tax increases, promotion bans, warning 
labels, restrictions on public smoking and the introduction of cessation services. This 
conveniently helped to assuage concerns by tobacco-producing countries that the 
emphasis might be on supply reduction.
However, while the appetite was growing for the development of an international 
tobacco control agreement, the negotiations themselves were far from straightforward. 
An International Negotiating Body was established. It met for six sessions, each 
lasting for between one and two weeks to negotiate the text, between October 
2000 and February 2003. While ostensibly a public health negotiation, there were 
many competing interests within the government delegations - particularly between 
representatives of ministries of finance, commerce, trade and foreign affairs. The 
USA, China, Japan and Germany were the major bulwarks, attempting to water down 
provisions because of their tobacco interests. The USA was also traditionally not in 
favour of being bound by any international treaties.
Despite a process described as “tedious, contentious and often confusing”,22 
consensus on the text was eventually reached. The FCTC entered into force in 
February 2005 and was signed by 168 countries during its 12-month open period. To 
date, 181 countries have both signed and ratified the FCTC, which means it has been 
approved by domestic parliaments. Six countries, including the USA, have signed but 
not ratified, while nine countries have done neither.
The FCTC put tobacco control on the international health agenda and presented  
a political multilateral challenge to the multinational tobacco industry. 
the Fctc presented 
a political multilateral 
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3: international tobacco 
control: structure and 
functions
A framework convention is a legally binding treaty. A government that ratifies a framework 
convention is then required to adopt implementing legislation. A framework convention 
establishes broader commitments for Parties and leaves the setting of specific targets 
either to subsequent more detailed agreements (usually called Protocols) or to national 
legislation. In essence, a framework agreement is an umbrella document which lays 
down principles, objectives and the rules of governance.
A framework convention is used where the issue is not confined to specific interests, 
but has global implications, where there is no consensus for strong substantive 
measures and where both the scientific understanding and the issue being addressed 
are both evolving. There are only two framework conventions: the most well-known 
example is the Framework Convention on Climate Change (see also page 23).
Framework conventions tend not to have time-bound obligations (although the FCTC 
has two). This is usually left to detailed provisions in Protocols (or sub-treaties) which 
drill down into detail on a specific aspect within a framework convention, such as the 
Kyoto Protocol and the Montreal Protocol of the FCCC, and the Elimination of Illicit 
Trade Protocol to the FCTC. Protocols are stand-alone treaties and have their own 
administrative requirements for entry into force. 
A framework convention is said to be ‘legally binding’, but this is not the same as  
a legally binding contract as most people understand the term. It is legally binding on 
the state or government to implement the obligations into domestic law according 
to national interpretation. In truth, it is an agreement between nations that they will 
act in good faith in pursuit of the goals of the convention. That said, the Framework 
Convention on Climate Change is taken very seriously – all nations are interdependent 
on this issue. The cross-border implications for the environment are huge where  
a country might renege on its commitments. There are also significant political 
pressures to tackle climate change on the domestic front, such as setting targets 
and goals for reducing carbon emissions, investing in alternative sources of energy, 
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Notwithstanding the obligation to act in good faith and keep promises, the 1969 
Vienna Convention on the Law of Treaties23 (which governs the laws of treaties and 
interpretation) has an interesting provision which could easily be applied to the current 
disruption caused by newly developed safer nicotine products. Article 62 allows for 
an individual nation to set aside treaty obligations where there is a “fundamental 
change of circumstances” which could not have been predicted at the time the treaty 
was being negotiated. The Preamble to the FCTC itself notes potential changes and a 
determination “to promote measures of tobacco control based on current and relevant 
scientific, technical and economic considerations.”24
The Framework Convention 
on Tobacco Control (FCTC)25
The FCTC comprises 38 Articles and non-binding Guidelines to some of the Articles to 
assist Parties to deliver national obligations. There are Guidelines covering Article 5.3 
(protecting health policies from commercial interests); Articles 8. 9 and 10 (protection 
from tobacco smoke; tobacco product content and testing); and Articles 11-14 (product 
packaging; public awareness; advertising; and demand reduction including cessation 
services).
There is currently one Protocol – the Protocol to Eliminate the Illegal Trade in Tobacco 
Products, which complements Article 15, Illicit Trade in Tobacco Products. 
The Preamble to the FCTC has several recitals which are unambiguous in recognising 
the need to reduce death and disease from the use of tobacco. These recitals are 
given within the context of the universal right to health with nobody left behind and 
include;
“Determined to give priority to protect public health.”
“Reflecting…the devastating worldwide… consequences of…exposure to tobacco 
smoke.”
23 Vienna Convention on the Law of Treaties (1969) https://legal.un.org/ilc/texts/instruments/english/conventions/1_1_1969.pdf
24 Op cit, ref 4, p.3
25 The Framework Convention on Tobacco Control (2005): https://www.who.int/fctc/text_download/en/
A ‘no smoking’ sign amid city office blocks. 
Credit: Possessed Photography on Unsplash
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“Seriously concerned about increase in worldwide consumption…particularly in 
developing countries…and the burden this places on families, on the poor and 
on national health systems”.
“Recalling Article 12 of the International Covenant on Economic, Social and 
Cultural Rights…which states that it is the right of everyone to the enjoyment of 
the highest attainable standard of physical and mental health.”
“Recalling…the Constitution of the [WHO] which states that [the right stated 
above] is a ‘fundamental right of every human being’.
“Determined to promote measures of tobacco control based on current and 
relevant scientific, technical and economic considerations.”
The Conference of the Parties (COP)
At the centre of the FCTC decision-making process is the biennial meeting of the 
nations who are Parties to the FCTC, known as the Conference of the Parties (COP). 
Party (or nation) representatives might sign the FCTC as an indication of intent, but 
the signing will not be ratified unless it is agreed by the Parliament of the country. This 
indicates that the Party has formally agreed to comply with the FCTC – although there 
are no ‘sanctions’ for non-compliance.
Parties who have both signed and ratified the FCTC or who have acceded to the 
FCTC can take an active role in discussions and decisions at COP. Those who have 
only signed (like the USA) have observer status and can intervene only when all other 
Parties have spoken. The views of those who have only signed do not have to be 
formally considered.
Since the first COP in 2006, there have been eight meetings in different locations 
around the world with the ninth set for November 2021, postponed from 2020 due to 
COVID.26
26 Information about COP 9, held virtually in November 2021, can be accessed here: https://fctc.who.int/who-fctc/
governance/conference-of-the-parties/ninth-session-of-the-conference-of-the-parties 
The WHO Executive Board Room.
Source: Wikimedia Commons
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Delegations will primarily consist of health officials, although other domestic 
departmental interests concerning, for example, business and trade might also attend. 
Delegations might also include NGO representatives and subject specialists.
At COP meetings, decisions are taken by consensus; voting is a very rare occurrence. 
If only one country opposes a provision, either the country concedes, or there is a text 
amendment that all must agree on. Every Party carries equal weight. 
Structure of the meetings
Apart from the main plenary sessions that involve all Parties, the COP breaks into two 
committees – Committee A and Committee B. Committee A deals with policy matters 
and Committee B deals with matters such as funding. The Committees are there to 
discuss agenda items such as proposals put forward by Parties, and sometimes to draft 
decisions to enable consensus to be reached in the plenary sessions. Sub-drafting 
groups may be convened if consensus cannot be reached in Committee.
A world of pre-meetings
Parties that wish to make proposals for inclusion on the COP agenda will do so some 
months before the agenda is circulated. The positions that governments will take are 
usually decided well before the meeting. This means that the COP sessions are largely 
an exercise in rubber stamping. However, a degree of horse trading may take place in 
the Committee meetings.
Much of the pre-meeting discussion and positioning goes on in the WHO Regional 
Meetings in advance of a COP. There are six WHO regions; Africa (AFRO); the Americas 
(AMRO); South-East Asia (SEARO); Western Pacific (WPRO); Europe (EURO) and 
Eastern Mediterranean (EMRO). Parties can speak for themselves at the COP, but are 
encouraged to allow the elected country for the region to do the talking, to save time 
and consolidate issues.
Credit: Atlas of MS toolkit 
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Informing decision-making
One COP may decide that it needs to explore specific issues for a report to the next 
COP. This can happen through two channels:
1. Working Groups
These comprise COP delegates (up to around 40 in number) with equal representation 
from the six WHO regions who might, for example, work on developing guidelines for 
specific FCTC Articles.
2. Expert Groups
These are convened by the FCTC Secretariat (see below) acting on a request of the 
COP to report on specific technical issues such as legal. 
There are also standing expert groups including the Tobacco Laboratory Network 
(TobLabNet), which develops standard testing and measurement methods for tobacco 
products, and the WHO Study Group on Tobacco Product Regulations (TobReg), which 
focuses on tobacco and nicotine science and policy.
The COP support network
1. The WHO
The COP meetings are hosted by the WHO. However, the WHO does not have 
an official voice in the negotiations. It cannot propose amendments to the text. 
Nevertheless, the WHO can intervene to assist negotiations and encourage 
governments to endorse WHO views on tobacco control.  It has considerable influence, 
since most countries are passive and say and initiate nothing. Most will go with the 
flow, which is different to other substantive global issues such as trade and climate, 
where national governments fight strongly for national positions and leadership. 
2. The FCTC Secretariat
This is the administrative body that supports the COP. It is funded by Parties, both in 
the form of assessed contributions for mainstream Secretariat work, and voluntary 
contributions for specific projects. Although housed within the WHO HQ in Geneva, the 
WHO has no direct line management of the Secretariat nor does the WHO have direct 
input into COP discussions and decisions. 
the head of the 
secretariat reports to the 
cOP, but the relationship 
is not one of supervision 
nor line management
Geneva, the home of the WHO. 
Credit: Lukas Blaskevicius on Unsplash 
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The Secretariat coordinates all the work that goes on in and between the COP 
meetings and produces all the necessary documentation including proposals for the 
COP agenda. The FCTC is required to act in accordance with the Parties’ wishes and 
proposals. As well as appointed officials, there is an inner group of advisers within the 
Secretariat known as ‘The Bureau’, composed of a president, five vice-presidents and 
six regional coordinators. They are elected at the end of each COP and finish their term 
at the conclusion of the next. 
It would appear that the WHO Director-General appoints the head of the Secretariat, 
usually from within the WHO ‘family’. The head of the Secretariat reports to the COP, 
but the relationship is not one of supervision nor line management. 
The FCTC is funded by a combination of assessed and voluntary contributions from the 
Parties. The assessment is made on the basis of a formula related to gross domestic 
product (GDP). Few countries pay the amount they owe, including several of the Parties 
with the highest assessed contributions.
3. The WHO Tobacco Free Initiative (TFI)
This is the WHO’s tobacco control arm, providing policy and legal advice to Parties, 
preparing draft provisions and brokering negotiating compromises. It is also the 
public face of WHO tobacco control policies and programmes. The TFI used to be a 
department in its own right, with its own Director. It has since been subsumed into the 
WHO department working to tackle NCD.
The role of COP non-state observers
So far, we have outlined a hinterland network of meetings, information and technical 
support provided to Parties and organised by WHO officials and appointed experts.  
But the influence on the deliberations of the COP does not end there.
The preamble to the FCTC recognises the “special contribution of non-governmental 
organizations and other members of civil society…to tobacco control efforts nationally 
and internationally…” NGOs are allowed a presence at the COP, but only those 
specifically accredited by the WHO.  International non-governmental organisations can 
apply for WHO accreditation. Smaller NGOs can participate as members of the NGO 
tobacco control umbrella body known as the Framework Convention Alliance (FCA), 
but membership is dependent on FCA acceptance. 









Assessed and paid contributions to the FCTC. 
Data source: FCTC/COP/9/14. (2021). Payment of the assessed contributions and measures to reduce Parties in arrears. 
Provisional agenda item 6.3. https://untobaccocontrol.org/downloads/cop9/main-documents/FCTC_COP9_14_EN.pdf
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Accredited FCTC NGOs can participate in negotiations and make interventions when 
invited by the session Chair once Parties have concluded. They might also be allowed 
to attend the Committee A or B meetings but not small working groups. These are 
where all the serious work is carried out, if there are still matters of conflict which have 
not been resolved in all the meetings which have taken place in the period since the 
previous COP.
FCA accreditation is only open to those with no connections to the tobacco industry, 
however tangential or historical. Also excluded are advocacy NGOs representing 
people directly affected by tobacco control regimes, who include smokers and, now, 
users of safer nicotine products. 
Unfortunately many influential stakeholders believe that anyone who advocates for 
tobacco harm reduction using SNP must be linked to, in the pay of or apologists for 
the tobacco industry. This is due to the involvement of the tobacco industry in the 
production of some (but by no means all) of the safer nicotine products on the market. 
Advocacy organisations in favour of tobacco harm reduction, including numerous 
vaping or snus consumer advocacy organisations, are therefore excluded de facto and 
get no seat at the table.
 
A breath of fresh air?
The FCTC COP, an international meeting of government ministers and officials 
ultimately funded by citizens’ taxes, is shrouded in a secrecy comparable to the UN 
Security Council. 
This is in stark contrast to the Framework Convention on Climate Change (FCCC) COP 
meeting. The FCCC COP 26 is due to take place in November 2021, the same month 
as the FCTC COP 9. The world’s media is already very engaged with the FCCC COP 26 
meeting and its potential to affect change. Mainstream media has barely picked up on 
the FCTC COP 9. 
At the FCCC COP, observers representing a broad range of interests are admitted; 
environmental, agriculture, indigenous communities, women’s issues, gender issues 
and youth groups - along with research and academic interests, labour unions and 
representatives from business. Applicants need only demonstrate that they represent  
a national or international body and have relevant knowledge and experience.27  
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The type, number and impact of business representation at the Climate Change COP 
is not without controversy. Delegates from heavily-polluting legacy industries, including 
coal, oil, gas, automobile and mining, attend. Under the convention’s own rules, it is 
permitted for trade bodies representing oil and gas to attend annual talks and inter-
sessional meetings as observers. At some previous COPs, major polluters have even 
been allowed to sponsor the meetings, with car manufacturers, energy companies and 
coal producers paying millions to get their brands front and centre. At COP 26, the UK 
government has stated that sponsors must “have a credible plan to cut their emissions 
to net zero by 2050”.28
Sponsorship deals aside, there may be an interesting point to be made about these 
industries being ‘in the room’ at COP meetings. Tackling the climate emergency 
requires engagement with the very industries that have contributed so significantly 
to the crisis. Failure to transform these companies and the way they operate will only 
hinder progress towards the ultimate goals of the Framework Convention on Climate 
Change. The meetings and the attendant media and political focus puts the spotlight 
on the progress or lack of progress in transitioning to greener technologies, processes 
and products. Yet the car manufacturers present at the COP26 to demonstrate their 
new electric vehicles are still actively selling vehicles with combustion engines. 
The contrast with the FCTC COP could not be more stark. Decisions at COP have the 
potential to affect the lives of millions of people worldwide, including the approximately 
100 million people29 who have already switched from smoking to use safer nicotine 
products, the 1.1 billion people who continue to smoke, their families and others at risk 
from inhaling secondhand smoke.  There are a huge number of organisations that 
need to be onside to implement the significant changes that are required to bring 
about an end to the death and disease caused by smoking – and pragmatically, that 
includes manufacturers. 
A protest against political inactivity on climate change. 
Credit: Marcus Spiske on Unsplash
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28 Climate Change News (18/08/20) ‘Big oil need not apply’. Accessed August 2021.  https://www.climatechangenews.
com/2020/08/18/big-oil-need-not-apply-uk-raises-bar-un-climate-summit-sponsorship/ 
29 Burning Issues: The Global State of Tobacco Harm Reduction 2020. Knowledge-Action-Change, 2020, p.54  
https://gsthr.org/report/2020/burning-issues/chapter-2#unrialisedpublichealth
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Beyond ‘quit or die’
The way international tobacco control plays out leaves the adult smoker two options 
– crudely put ‘quit or die’. Many of the gains in reducing smoking death and disease 
in HIC were achieved before the FCTC was enacted. Moreover, 154 countries had 
implemented some tobacco control measures before 2005. It would be wrong to 
suggest that, for example, public smoking bans or price rises have had no impact on 
prevalence and so, therefore, on death and disease. But since the 1970s, there has 
been a move away from smoking in HIC, as part of a gradual move towards ‘healthier 
lifestyles’, largely among people from higher socioeconomic groups (with high smoking 
rates still present among many marginalised and poorer communities in HIC).30 
As we pointed out above, the reality is that the current international tobacco control 
efforts are simply not enough. As of 2021, even in HIC, smoking prevalence graphs 
are levelling out while population growth is predicted to result in a rise in smoking 
prevalence in LMIC. 
There is, however, a complementary and potentially life-saving intervention which can 
be delivered at little cost to governments. It offers a third and more palatable option for 
current adult smokers. It is tobacco harm reduction using safer nicotine products. 
What is harm reduction?
Harm reduction is a range of pragmatic policies, regulations and actions that either 
reduce health risks by providing safer forms of products or substances or encourage 
less risky behaviours with an important role in championing social justice and human 
rights for people who are often among the most marginalised in society. Proponents 
of harm reduction argue that people should not forfeit their right to health if they 
are undertaking potentially risky activities, like drug or alcohol use, sexual activity or 
smoking.
Data source: Tobacco Control Laws. (2021). Retrieved September 2, 2021, from https://www.tobaccocontrollaws.org/
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30 Ibid, p. 140–146. Chapter 7: The right to health and the people left behind https://gsthr.org/report/2020/burning-issues/
chapter-7 
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While harm reduction as a social movement is relatively new, what affected 
communities have always been fighting for – the right to health, with nobody left 
behind – has long been enshrined in international conventions and continues to be so. 
The WHO is signed up to harm reduction across many of its activities.
People who use nicotine have the same fundamental right to enjoy the highest 
attainable standard of health as those who do not. People who smoke to obtain 
nicotine therefore have the right to access accurate information and products that help 
them achieve this.
Tobacco harm reduction: from conception 
to reality
While specifically referenced in the FCTC under Article 1d, harm reduction per se is not 
defined. It was included because the FCTC transition team sat down with the industry 
to hear what its plans were to produce safer products. 
On 13 October 2000, the WHO Director-General Dr Gro Brundtland made a statement 
in which she acknowledged the clear differences which existed between the priorities 
of public health and the industry, but even so, that “we are committed to hearing how 
the tobacco companies do propose to reduce the harm their products cause”.31 
It would be years before safer products became available, but the possibility of new 
developments was recognised in Recital 21 of the FCTC Preamble that Parties are, 
“Determined to promote measures of tobacco control based on current and relevant 
scientific, technical and economic considerations”. Even as recently as 2014, in a 
paper on new nicotine products prepared for COP 6, the WHO stated, “the greater 
responsibility to prove claims about ENDS scientifically should remain with the industry”.32
Fifteen years after vaping products emerged onto the market, what is the evidence 
that safer nicotine products are exactly that? There is one simple scientific fact which 
underpins the relative safety of SNP – there is no combustion of tobacco. 
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31 WHO Director-General’s response to the tobacco hearings. 13 October 2000, p.3.
32 WHO. Electronic nicotine delivery systems: report by the WHO. WHO, 2014, FCTC/COP6/10-21 July 2014, para 35, p.10
Combustion of tobacco is the key difference. 
Credit: Gary Ellis on Unsplash
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When a cigarette is lit, some 7,000 chemicals are released which are responsible for 
all the harms of smoking; cancer, heart and respiratory diseases. Smokers smoke 
tobacco because they are looking to experience the effects of nicotine, but suffer 
disease and might die because of the toxins in the smoke that is released when 
tobacco is burned. 
Safer nicotine products deliver nicotine to the user without combustion of tobacco. But 
what about nicotine itself? Issues of ‘nicotine illiteracy’ among health professionals and 
the public persist. Many mistakenly believe that nicotine itself is carcinogenic33,34,35; in 
fact, as the UK Royal College of Physicians has stated, “it is widely accepted that any 
long-term hazards of nicotine are likely to be of minimal consequence in relation to 
those associated with continued tobacco use.”36 
‘Nicotine addiction’ is also often cited as a concern. However, ‘addiction’ is a loaded 
term, which can bring to mind the damage to individuals, families and wider society 
caused by serious illicit drug problems. Nicotine itself is a relatively benign substance, 
used in pharmaceutical nicotine replacement therapies, which does not cause any of 
the illnesses associated with smoking. Using nicotine is arguably not the physical or 
psychological problem usually conveyed by the public image of the word ‘addiction’.37
The harm reduction potential for non-combustible nicotine products was realised 
by British tobacco researcher Professor Michael Russell as far back as 1976, but the 
products to deliver on the promise were not available in a form acceptable to smokers. 
Now they are and the evidence is growing substantially.
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33 Moysidou, A. et al. (2016). Knowledge and Perceptions about Nicotine, Nicotine Replacement Therapies and Electronic 
Cigarettes among Healthcare Professionals in Greece. International Journal of Environmental Research and Public Health, 
13(5). https://doi.org/10.3390/ijerph13050514 
34 Ratschen, E. et al. (2009). Tobacco dependence, treatment and smoke-free policies: a survey of mental health 
professionals’ knowledge and attitudes. General Hospital Psychiatry, 31(6), 576–582. https://doi.org/10.1016/j.
genhosppsych.2009.08.003 
35 Ramesh Patwardhan, S., & Murphy, M. A. (2013). Survey of GPs’ understanding of tobacco and nicotine products. Drugs 
and Alcohol Today, 13(2), 119–150. https://doi.org/10.1108/DAT-02-2013-0010 
36 Royal College of Physicians (RCP) (2016). Nicotine without smoke; tobacco harm reduction. A report by the Tobacco 
Advisory Group of the Royal College of Physicians. https://www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-
tobacco-harm-reduction
37 Tobacco Harm Reduction: A Burning Issue for Asia. London: Knowledge Action Change (2021), p.18.  
https://gsthr.org/report/2021/burning-issue-for-asia/chapter-3  
Vaping device showing heated coils. 
Credit: Boukaih on Unsplash
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Tobacco harm reduction was advocated by the UK Royal College of Physicians (RCP) 
in the 2007 report Harm reduction in nicotine addiction.38 The report argued that 
“harm reduction in smoking can be achieved by providing smokers with safer sources 
of nicotine that are acceptable and effective cigarette substitutes” and suggested the 
potential for rebalancing the market in favour of the safest nicotine products.39
In 2017, in a position statement on vaping products, the UK Royal College of General 
Practitioners said, “The evidence so far shows that e-cigarettes have significantly 
reduced levels of key toxicants compared to cigarettes, with average levels of 
exposure falling well below the thresholds for concern.”40
In 2020, Public Health England reaffirmed its earlier conclusion that “vaping is at least 
95 per cent less harmful than smoking”.41
Not only is the evidence base growing, so is the global market demonstrating that if 
smokers are given the option of safer nicotine products which are available, affordable, 
accessible and appropriate, they will switch. By 2020, the Global State of Tobacco 
Harm Reduction calculated that there were nearly 100 million users of safer nicotine 
products, primarily vaping products, but also heated tobacco products and oral 
products like Swedish-style snus.42
 
Tobacco harm reduction works
In Burning Issues: The Global State of Tobacco Harm Reduction 2020 report, we offer 
strong epidemiological evidence of a substitution effect, where smokers are switching 
to safer nicotine, in four countries. 
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38 Tobacco Advisory Group, Royal College of Physicians. Harm reduction in nicotine addiction: helping people who can’t quit. 
London, RCP, 2007. 
39 Ibid. 
40 Royal College of General Practitioners Position Statement on the use of electronic nicotine vapour products (September 
2017). https://www.rcgp.org.uk/-/media/Files/Policy/2017/RCGP-E-cig-position-statement-sept-2017.ashx?la=en 
41 Public Health England (2020) Vaping in England – 2020 evidence update summary. https://www.gov.uk/government/
publications/vaping-in-england-evidence-update-march-2020/vaping-in-england-2020-evidence-update-summary 
42 Burning Issues: The Global State of Tobacco Harm Reduction 2020. Knowledge-Action-Change, 2020, p.51–53. 
https://gsthr.org/report/2020/burning-issues/chapter-2#windowsofopportunity
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In Sweden, a tradition of using snus, an oral tobacco, had been present for centuries. 
It was in the 20th century however that snus manufacturing processes became 
significantly more safety-focused. By 1996, the use of this new, safer, pasteurised snus 
overtook smoking among men. Sweden now has the lowest level of smoking among 
men in the EU – 5 per cent against the EU average of 24 per cent. Sweden also boasts 
the lowest death rate per 100,000 attributable to tobacco in men aged 30 or older. If 
the EU ban on snus was revoked, it is calculated that around 320,000 tobacco-related 
premature deaths among men aged 30 years or older could be prevented in the EU 
every year.43
At a mere 1 per cent, Norway has the lowest rate of smoking among women under the 
age of 25 in the world; this has been driven by the substitution of snus for cigarettes 
– 15 per cent of young women use snus. Generally, use of snus is replacing cigarette 
smoking in the country.
A similar picture can be seen in Iceland, where the uptake of snus and vaping products 
has been matched by a fall in smoking.
In Japan, the introduction of heated tobacco products has seen dramatic falls in sales 
of cigarettes, down by 32 per cent in five years. Heated tobacco products now account 
for a third of all tobacco sales.44 
Tobacco harm reduction at work
So how have the WHO, its NGO and funding allies responded to these disruptive 
technologies and the opportunities they present to make more tangible inroads into 
reducing death and disease from smoking?
43 Lars Ramström, Institute for Tobacco Studies, Sweden. Poster for the Global Forum on Nicotine 2017, quoted in No Fire, No 
Smoke: Global State of Tobacco Harm Reduction 2018. KAC: 2018, p.50 https://gsthr.org/resources/item/no-fire-no-smoke-
global-state-tobacco-harm-reduction-2018  
44 For more detail and full references, please see: Knowledge-Action-Change. No Fire, No Smoke: Global State of Tobacco 
Harm Reduction 2018. KAC: 2018, pp.45-50 https://gsthr.org/resources/item/no-fire-no-smoke-global-state-tobacco-harm-
reduction-2018, Knowledge-Action-Change. Burning Issues: Global State of Tobacco Harm Reduction, 2020. KAC: 2020, 
pp.51-53 https://gsthr.org/report/2020/burning-issues/chapter-2#windowsofopportunity 
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Data source: European Commission. (2021). Special Eurobarometer 506: Attitudes of Europeans towards tobacco and elec-
tronic cigarettes (S2240_506_ENG). European Commission. http://data.europa.eu/88u/dataset/S2240_506_ENG; Statistics 
Norway. (2021). Tobacco, alcohol and other drugs. SSB. https://www.ssb.no/en/helse/helseforhold-og-levevaner/statistikk/
royk-alkohol-og-andre-rusmidler; Japanese domestic cigarette monthly sales results (Information by Business Segment). 
(2020). Japan Tobacco Inc. https://www.jt.com/investors/results/S_information/domestic_cigarette/index.html
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5: trench warfare: 
the WhO, allies and funders
A new front opens up
The history of domestic and international tobacco control has been dominated by 
attempts to curb the power of the tobacco industry and expose its manifold strategies 
for undermining laws and regulations. Cigarette consumption has been falling in HIC 
in recent decades. Yet the global value of the cigarette market is predicted to continue 
rising substantially, mainly through sales in LMIC. The battle against combustible 
products is far from over and nobody would suggest stepping back from that. But there 
are alternate strategies to be deployed now.
THR has a complementary role to play in tobacco control and reducing cigarette 
consumption. Its potential can come to fruition if the international tobacco control 
community, led by the WHO, can disaggregate combustible from non-combustible 
tobacco products in its policy and legislative deliberations. 
As it stands, all nicotine products are regarded by many of the powerful forces of 
international tobacco control as being equally dangerous, warranting either total bans 
or to be heavily regulated as if they were combustible tobacco products. This approach 
saves tobacco control from having to disrupt a deeply entrenched policy mindset. It 
also enables a new front to open up in the war against the tobacco industry, serving 
certain moral and financial vested interests. 
 
 
Despite the general failings of current strategies to curb smoking, especially in LMIC, 
and the scarcity of global smoking cessation services, it is becoming apparent that:
» The original wording and intention of the FCTC notwithstanding, the policy and 
legislative goalposts have shifted from tobacco and smoking – and now to an entirely 
prohibitionist stance targeting nicotine irrespective of the delivery mechanism. 
» Anti-THR campaigning and funding is focused on preventing young people initiating 
nicotine use. This has the advantage of being beyond political criticism. At the same 
time, it is impossible to evaluate without long-term, expensive longitudinal studies. 
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Image depicts a child purportedly vaping. See page 37 for more examples of the WHO using children in its campaigns. 
Source: WHO World No Tobacco Day 2020
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Process and activity boxes can be ticked, while measurable health outcomes are 
conveniently forgotten.
» The prohibitionist agenda speaks to a moral conclusion that current adult smokers 
have only themselves to blame, leaving them with the stark choice to ‘quit or die’. 
» By sowing doubt and confusion in the minds of smokers, health professionals, the 
media and wider society about the relative safety of SNP and their potential for 
helping adult smokers switch away from smoking, the WHO and its allies have taken 
a leaf out of the old-style tobacco industry playbook.
How does this play out on the ground? There are four key actors: the FCTC Secretariat; 
the WHO TFI, anti-THR NGOs and Bloomberg Philanthropies. Although these are 
iterated individually below, they form a close interdependent and overlapping network 
of influence on Parties to the FCTC and their tobacco control policies.
FCTC Secretariat – tobacco control 
out of control
For anyone with a knowledge of harm reduction and its implementation in other areas 
of health policy, the FCTC Secretariat’s outright opposition to tobacco harm reduction 
is a source of considerable frustration. Harm reduction sits right at the heart of WHO 
policy to reduce the risk of death and disease caused by HIV and injecting drug use. 
WHO explicitly supports the implementation of harm reduction programmes, which 
include the distribution of condoms and clean needles, or the provision of opioid 
substitution therapy for people dependent on heroin or other opiates.45 
The WHO estimates that there are 11 million people who inject drugs worldwide and 
that injecting drug use accounts for 10 per cent of all new HIV infections.46 There are 
1.1 billion people who smoke around the world, 8 million people a year who die from 
smoking-related diseases and an estimated 14 per cent of all NCD deaths among 
adults aged 30 years and over are tobacco-related.  
Despite the huge potential to make significant public health gains in the fight to 
reduce the smoking-related death and disease affecting millions worldwide, it seems 
as though there are no connections made between the WHO’s pragmatic and non-
moralistic policy approach to harm reduction for HIV and injecting drug use and that for 
tobacco.   
 
A condom. Credit: Reproductive Health Supplies Coalition on Unsplash
Syringes. Credit: John Cameron on Unsplash
Opioid substitution therapy. Credit: Josh Estey, AusAID on Wikimedia Commons
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45 WHO Regional Office For Europe, Policy guidance by HIV intervention area: harm reduction https://www.euro.who.int/en/
health-topics/communicable-diseases/hivaids/policy/policy-guidance-for-areas-of-intervention/harm-reduction  
46 WHO, Global HIV, Hepatitis and STI Programmes: People who inject drugs 
https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/populations/people-who-inject-drugs
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How has this happened? Whatever the formal structures look like, in reality the 
Secretariat is very influential in the flow of information to the COP from outside sources. 
It guides which proposals find their way onto the agenda and how they are phrased. 
To reiterate, while the WHO hosts the FCTC Secretariat, it does not have any direct 
line management control – nor is it clear who does. Combined with a lessening of 
interest in tobacco control on the part of Parties and, more recently, the WHO’s focus 
on COVID, this has allowed what one correspondent has called ‘rogue elements’ within 
the FCTC to thread a prohibitionist, anti-THR agenda through Convention deliberations. 
This is made manifest in the papers submitted to different COP meetings over the years.
The COP and the history of SNP
The WHO first considered ‘ENDS’ in 2010 with a regulatory consultation exercise prior 
to COP 4. The report that went to the COP recommended extreme caution when it 
came to these new products. 
Another report was ordered for COP 5 in 2012. This recommended the new products 
should not be regarded as safer alternatives to combustible tobacco products.
By the time the next paper was prepared for the COP meeting of 2014, it was clear 
that the report commissioned by the FCTC Secretariat saw no benefit in encouraging 
a switch to vaping products. It was deemed this would be entirely outside of both the 
spirit and the letter of the FCTC, to the extent that “while medicinal use of nicotine is a 
public health option under the treaty, recreational use is not”.47
The 2016 COP meeting had more positive comments on THR and the potential for 
ENDS.  Drawing heavily on a TobReg Report48, the Decision at COP 7 was to ‘welcome’ 
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A range of vaping devices and liquids. 
Credit: Antonin FELS on Unsplash
47 WHO. Electronic nicotine delivery systems: report by WHO. Prepared for FCTC/COP 6, September 2014, p. 10. See also: 
https://www.who.int/publications/m/item/background-papers-to-the-who-report-on-electronic-nicotine-delivery-systems-
and-electronic-non-nicotine-delivery-systems-(ends-ennds) (2016); https://www.who.int/fctc/cop/sessions/cop8/FCTC_
COP8(22).pdf (2018)  
48 FCTC/COP/7/11 Report: Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS/
ENNDS): Report by WHO https://www.who.int/fctc/cop/cop7/FCTC_COP_7_11_EN.pdf 
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the report which included the following statement: “If the great majority of tobacco 
smokers who are unable or unwilling to quit would switch without delay to using an 
alternative source of nicotine with lower health risks, and eventually stop using it, this 
would represent a significant contemporary public health achievement.”49 The Decision 
went on to describe a number of options for regulating ENDS. 
Unfortunately, these recommendations were preceded by a statement about banning 
products, with the implication that this was the preferred policy option. A very thin 2018 
paper simply reiterated the points for Party consideration in the previous paper. 
Safer nicotine products at COP 9 
Two new papers were tabled for COP 9 relating to safer nicotine products, which 
were published within days of each other in July 2021. The first, by the WHO, is titled 
a ‘Comprehensive report on research and evidence on novel and emerging tobacco 
products, in particular heated tobacco products’.50 The second, by the Convention 
Secretariat, considers ‘Challenges posed by and classification of novel and emerging 
tobacco products’.51 Both reports focus on heated tobacco and ENDS (with no mention 
of snus or nicotine pouches). 
 
However, when the Provisional Agenda for COP 9 was published, it was revealed 
that “the Bureau [had] decided that [these two] reports [...] should be presented for 
information and that related substantive discussions should be deferred to COP 10.”52 
If a Party or Parties wish to discuss the papers they can decide to raise them – but 
discussion may well have to wait until COP 10 in 2023. 
49 FCTC/COP/7/9 Decision: Electronic nicotine delivery systems and electronic non nicotine delivery systems 
https://www.who.int/fctc/cop/cop7/FCTC_COP7_9_EN.pdf?ua=1   
50 FCTC/COP/9/9 Comprehensive report on research and evidence on novel and emerging tobacco products, in particular 
heated tobacco products, in response to paragraphs 2(a)–(d) of decision FCTC/COP8(22): report by WHO. 
https://untobaccocontrol.org/downloads/cop9/main-documents/FCTC_COP9_9_EN.pdf 
51 FCTC/COP/9/10 Challenges posed by and classification of novel and emerging tobacco products: report by Convention 
Secretariat https://untobaccocontrol.org/downloads/cop9/main-documents/FCTC_COP9_10_EN.pdf
52 FCTC COP 9 Provisional agenda annotated https://untobaccocontrol.org/downloads/cop9/main-documents/FCTC_
COP_9_1_annotated_EN.pdf
A heated tobacco device. 
Source: Wikimedia Commons
34 gsthr.org
None of these papers concede at any point that any of the products discussed could 
have a role in reducing the burden of death and disease from smoking.
It is also worth highlighting here the WHO study group on tobacco product regulation, 
commonly known as TobReg. This is a long-standing scientific advisory committee, 
which has produced some useful reports. However, its latest report (2021)53 contained 
a dozen recommendations which underpin general WHO intransigence to SNP and are 
hostile to the idea SNP offer public health benefits in tackling the smoking epidemic. 
The text puts harm reduction in quote marks. It refers to “claims” of less harm and 
“alleged belief” in less harm. The word ‘may’ is used frequently, for example when 
it states that young people “may” be attracted to e-liquid flavours or “may” go on to 
smoke combustible cigarettes, without offering any substantive evidence to support 
the assertions. There are also sneering references to “fancy” IQOS concept stores.53 
Guidelines
The most contentious and deliberate method of attack on supporters of THR is the 
over-interpretation of the Guidelines for Article 5.3. Given the time period in which the 
FCTC was drafted and the industry track record, the wording of the original article was 
perfectly reasonable:
“In setting and implementing their public health policies with respect to tobacco 
control, Parties shall act to protect these policies from commercial and other 
vested interests of the tobacco industry in accordance with national law.”
It is important to note that even in the context of a ‘good faith’ convention, FCTC 
Guidelines are non-binding proposals: they are merely guides to assist Parties to 
implement their obligations in various articles. They do not extend the obligations of 
the FCTC nor do they constitute a subsequent interpretation of the FCTC. This is the 
basis on which Parties agree to the adoption of Guidelines.
A COP Working Group on Article 5.3, comprising two representatives from each WHO 
region, was constituted as part of the process of providing non-binding guidance on 
how Parties may interpret Article 5.3. The Working Group was to present proposals 
to the 2008 COP 3 meeting in Durban. Like much of the FCTC, the Guidelines on 5.3 
were primarily to assist LMIC. In the EU, for example, principles and guidelines were 
already in place. 
The main thrust was to set out in more detail the objective to limit as far as possible 
contact between governments and the industry, and to ensure that any dealings with 
the industry were as open and transparent as possible. While some Parties wanted 
tougher provisions and others pressured for a lighter touch, the Key Facilitator was 
aiming for a document that was balanced and proportionate. It was never intended 
that the Guidelines would be used to exclude the industry – or anyone else – from 
involvement in discussions related to tobacco use and tobacco products at either a 
domestic or international level.  
Yet, while the provisions of the 5.3 Guidelines remain reasonable, the opening Guiding 
Principle is now out of date: 
“There is a fundamental and irreconcilable conflict between the tobacco 
industry’s interests and public health policy interests.” 
53 WHO. WHO study group on tobacco product regulation. WHO, 2021. https://www.who.int/publications/i/
item/9789240022720   
54 Ibid. p54. See also a summary of the group’s recommendations on SNP to the WHO Executive Board which are highly 
damaging to the progress of THR. https://www.clivebates.com/documents/APPGVapingFeb2021.pdf p.19
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In the light of a new generation of demonstrably safer nicotine products being 
produced by both multinational companies and a significant contingent of middle and 
small manufacturers around the world, this principle is no longer sustainable. 
Traditional tobacco war thinking cannot be upheld in light of this disruption. How 
has international tobacco control responded? By deliberately over-interpreting and 
subverting Article 5.3 to extend the notion of ‘the tobacco industry’ so that any 
business, organisation, NGO, academic, consumer group or clinician who supports 
THR is included by default. The Guidelines have been invoked by state and non-state 
agencies across the world to engage in no-platforming and ad hominem attacks.
Article 5.3 – Guidelines fall-out
Ironically, while the Guidelines call for dealings with the industry to be accountable and 
transparent, the same cannot be said for the conduct of the COP meeting. Over time, 
the COP has become a self-referential echo chamber where dissenting voices are 
stifled by the over-interpretation of 5.3 Guidelines. 
During the initial FCTC negotiating meetings in 2000-2003 the public gallery was 
open to anybody to witness the deliberations. The same applied to the first three COP 
meetings. Over time, the general public – including media – has been excluded from 
all but the opening day plenary by a decision of the Parties. This is completely at odds 
with the way other UN agency meetings are conducted, including the Commission on 
Human Rights, the Commission on Narcotic Drugs and, as referenced above, the COP 
meeting on Climate Change. 
Image of portion snus. Source: Wikimedia Commons
A uniformed security guard at the United Nations. 
Credit: Manuel Elias, via UN Photo on flickr
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Any attempt to conduct UN meetings like this, outside of the UN Security Council, 
would not be tolerated by diplomats and government officials. The funding for UN and 
WHO meetings relies on public money donated by the Parties. It follows that there 
needs to be public accountability and transparency. Lack of transparency at COP 
needs to be raised with government accountability departments.
The level of paranoia and insecurity enveloping the COP hit a high point of absurdity in 
2014 when a representative from the International Crime Police Organisation (Interpol) 
was denied entry on the basis that Interpol had received money from a tobacco 
company to tackle the illicit market in cigarettes.55
There is a view that part of this demand for secrecy has come from health ministry 
delegations aiming to swerve around domestic opposition to tobacco control and 
anxious to avoid publicity. But it also plays to a patronising attitude towards LMIC – 
namely that their delegates need special ‘protection’ from industry influence.
Having established that the FCTC Secretariat wields unhealthy power within the FCTC/
COP universe, there remains the question of how WHO is operating against THR in the 
wider world.
WHO Tobacco Free Initiative (TFI)
The TFI is the public face of WHO tobacco control efforts. It drives the combined WHO 
and FCTC Secretariat anti-THR advocacy effort, which includes speeches, reports, 
social media channels, awards, events and online resources. The WHO is a trusted 
source of health information, so it is deeply troubling that via all these media, it has 
been the purveyor of entirely fabricated information about SNP, devoid of any robust 
evidence base. Several examples can be given, but three will suffice. 
In 2019, the Lancet published an article under the name of the WHO Director-
General, full of misinformation based on cherry-picked flawed studies relating to 
‘toxic emissions’ from vaping devices, risks of heart attack and lung damage, fetal 
abnormalities and impaired brain development, making the overall assertion that 
“ENDS are undoubtedly harmful” and should be regulated to the nth degree.56
On 20 January 2020, the WHO published a Q+A page on ENDS. The answers to the 
nine questions were severely criticised on social media. About ten days later, the Q+A 
was marginally updated, without any notification of changes or acknowledgement of 
errors. Even the updated version was full of false or misleading information, errors of 
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55 WHO (2014). Report of the sixth session of the Conference of the Parties to the WHO Framework Convention on Tobacco 
Control. Section 2.20, page 7. https://www.who.int/fctc/cop/sessions/COP6_report_FINAL_04122014.pdf    
56 Tedros Adhanom Ghebreyesus (2019) Progress in beating the tobacco epidemic. Lancet July 26, 2019 http://dx.doi.
org/10.1016/S0140-6736(19)31730-1 
Test tube rack with a range of vaping devices. Credit: CDC on Unsplash
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fact, exaggerations and over-simplifications covering general risks, addiction, lung 
damage, second-hand dangers and aids to cessation.57
Perhaps the most egregious example was the latest in the WHO series Report on the 
Global Tobacco Epidemic published in July 2021. This report was subtitled Addressing 
new and emerging products and for the first time devoted a whole chapter to SNP. 
There were large banner quotes at the beginning of the document declaring “ENDS 
should be strictly regulated for maximum protection of public health” and the equally 
bogus claim that “Children and adolescents who used ENDS can double their risk 
of smoking”. It is the visual portrayal of ‘children’ which is particularly disturbing. 
Every colour photo in the 200-page report bar one depicted a young child. Worse 
still, screenshots taken from the WHO report launch depicted two young people 
purportedly vaping while a third appears to show a baby reaching for a vaping device. 
In relation to child labour and tobacco farming, the WHO regularly references the UN 
Convention on the Rights of the Child. It would do well to get its own house in order 
with reference to Article 36 which states that “Governments must protect children from 
all…forms of exploitation, for example the exploitation of children for political activities, 
by the media or for medical research”.58
This emphasis on children and young people is the most obvious example of the 
influence of a third set of actors: NGOs, and in particular, the US-based Campaign for 
Tobacco Free Kids (CTFK).
 
Non-governmental organisations (NGOs)
Historically, anti-tobacco campaigners in the USA have scored considerable success 
against the tobacco industry. They have teamed up with state governments to bring 
about the Master Settlement Agreement, and campaigned for all the elements we 
see in tobacco control policies across the world – advertising, promotion and public 
smoking bans, warning labels and so on.
Anti-tobacco campaigners were also highly influential during the FCTC negotiating 
process. This caused disquiet for at least one member of the US delegation, Greg 
Jacob, who later described the FCTC negotiating process as “deeply flawed”.59
The FCTC negotiation was the first time the WHO had been involved in drafting an 
international health treaty. Many of the delegates were health ministers, including 
several doctors. Collectively, however, they knew little or nothing about international 
law and the process of treaty negotiations. Into the breach, wrote Jacob, came CTFK 
57 To read the full account and the resulting trenchant criticism, see: https://www.clivebates.com/world-health-organisation-
fails-at-science-and-fails-at-propaganda-the-sad-case-of-whos-anti-vaping-qa/ 
58 The United Nations Convention on the Rights of the Child (1989), p.10, accessed at UNICEF website: https://www.unicef.
org.uk/wp-content/uploads/2010/05/UNCRC_united_nations_convention_on_the_rights_of_the_child.pdf, 
59 Jacob, G. (2018). Administering the mark of Cain: secrecy and exclusion in the FCTC implementation process. Fordham 
International Law Journal: 41 (3), p.669-696 
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and US Action on Smoking and Health (ASH). They banded together with other NGOs 
to form the Framework Convention Alliance (FCA). Jacob contended,
“…the NGO advisers did not act as disinterested legal advisers and along the 
way more than one delegation was hoodwinked into believing the NGOs’ all-
too-frequently distorted version of the truth.” 
In a harbinger of the 5.3 scandals to come, Jacob reported on the discussions around 
the definition of “tobacco advertising and promotion”. It was clear to Jacob and most of 
the delegates in the meetings that the definition was ridiculously broad:
“It took a minor miracle just to get the word ‘commercial’ inserted in the 
definition… as many members of the [WHO regional groups] wanted the definition 
to cover non-commercial speech by actors outside the tobacco industry.” 
It was during these negotiations that NGOs indulged in what can only be described 
as the politics of the playground. Jacob alleges that representatives followed him 
around trying to eavesdrop on his phone conversations. They continued these antics 
in subsequent COP meetings doing ‘click and run’ sorties to photograph any industry 
representative in the building and putting these photos on a poster. One industry 
observer was literally followed into the toilet. There was public naming and shaming and 
the issuing of ‘Dirty Ashtray awards’ to delegations deemed to be obstructing progress.
But gesture politics aside, since the advent of SNP, the influence of western-based 
NGOs more broadly in international tobacco control has become increasingly inimical 
to the best interests of global public health.
At least in America, NGOs like CTFK were becoming victims of their own success. Legal 
victories over the tobacco industry, increasing rules and regulations about smoking 
and a decline in the number of both adult and teen smokers left the CTFK in danger of 
being an NGO without a mission.
The arrival of vaping devices in 2006-07 was manna from heaven for those who 
wanted to carry on the fight against the old enemy. To keep the agency alive, it was 
imperative that the new situation was entirely framed through the prism of past battles. 
The best way of doing that? Claim that the new products were no safer than cigarettes 
- and maybe even more dangerous. Big Tobacco was up to its old tricks trying to 
hook kids, but now it was doing it to compensate for falling cigarette sales. It could be 
argued that, in terms of its mission, the CTFK did not need to concern itself with adult 
smokers. But its activities were not only imparting false information to young people. 
Its powerful lobbying capacity was bending the ears of politicians to take action - to the 
detriment of the existing at-risk community of adult smokers.
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Even so, an entirely US-based campaign risked running out of steam. But then, with 
a massive injection of funding from Bloomberg Philanthropies (see below), CTFK 
suddenly found itself in a position to obtain global reach. The organisation could 
take on the world, advocating bans and strict regulations and utilising its well-honed 
‘kiddification’ programme to undermine the evidence base for SNP as a harm reduction 
option for adult smokers. 
Many HIC like those in the EU (tied to the EU Tobacco Products Directive), the USA, 
Australia, New Zealand, Japan, Canada and elsewhere already had regulations in place. 
Western-based NGOs like CTFK and the International Union Against Tuberculosis and 
Lung Disease (The Union) were aiming at LMIC. The central message delivered through 
webinars, press releases and other media was ‘Don’t bother to try and come to your own 
decisions about these products. The WHO says there is no merit in any of them. They are 
all bad, so just ban them.’ This was a ‘get out of jail free’ card for many health ministries to 
enact some laws with few resources for enforcement and consider the issue dealt with.
This approach is problematic on at least two levels.
1. Parachuting in ‘oven-ready’ tobacco control policies takes no account of the best 
public health interests of the population (and could be compared to neo-con US 
foreign policies aiming to ‘build democracy’). This particularly applies in LMIC, 
where most smokers live and die. These people could clearly benefit from access to 
accessible, affordable, appropriate and acceptable SNP.
2. Winning policy battles and pushing for law changes appeared to become the focus 
– irrespective of whether or not these would make any material difference to death 
and disease from smoking in those countries. The chances are they will not. The 
only element which appears to impact on use is taxation – but that drives those with 
the least income and most risk from smoking to the illicit market.
Leaked CTFK documents revealed a whole global strategy to include political 
advocacy, campaigning, legal assistance, public health and media training. The 
strategy appears to set out the goal of commandeering the tobacco control policies of 
many LMIC, rather than simply supporting them.60
with a massive 




Free Kids suddenly 
found itself in a position 
to obtain global reach
parachuting in ‘oven-
ready’ tobacco control 
policies takes no account 
of the best public 
health interests of the 
population
Union Position Paper on E-cigarettes and HTP sales in LMICs. (n.d.). The Union. Retrieved 20 July 2020, from  
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60 Minton, M. (2021), Exposed: Bloomberg’s anti-tobacco meddling in developing countries. https://cei.org/blog/exposed-
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by documents leaked to Minton.
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Thus a US-based NGO, with a brief to prevent smoking among US teens, has managed 
to undertake wide-ranging tobacco control activity across vast swathes of Latin 
America, Asia, and Africa. How? And how has the WHO TFI continued to operate on 
reduced donor contributions following the 2007-08 financial crash and now the global 
pandemic?
This leads us to our fourth actor – Bloomberg Philanthropies.
Bloomberg Philanthropies
Since the turn of the 20th century, rich US-based private foundations like Rockefeller, 
Carnegie and Ford gave millions of dollars to fund activities across society including 
scientific and medical research, technical innovation, education and arts and culture 
endowments.
Nowadays, the richest and most famous of these foundations is that established by Bill 
and Melinda Gates (BMGF). BMGF has donated to US domestic education programs 
but is best known for work overseas to tackle communicable diseases such as malaria. 
What is different about BMGF is that unlike its predecessors, it has been in the 
foreground of what economists Matthew Bishop and Michael Green call ‘philanthro-
capitalism’.61 This has two elements. The first is that the organisation is run more along 
the lines of a for-profit corporate enterprise with, for example, programme target-
setting and often micro-management of process. The second is, to put it crudely, “if we 
pull people out of poverty and make them healthy, they will buy more of our stuff”. Bill 
Gates said as much in an article for Time magazine in 2008.62
Whatever the business model, concerns have been expressed generally about the 
nature of these American private foundations. The first revolves around issues of 
accountability and transparency. They are obliged to submit tax forms containing basic 
information but are answerable to nobody apart from a handful of trustees. There 
are some details on websites about sums of money handed out, but the process of 
decision-making around grants remains hidden from public view. The second concern 
is the degree to which funds are eroding government support for public welfare and 
education. Thirdly are concerns about the provenance of foundation money. For 
example, Microsoft was the subject of several anti-trust lawsuits in the 1980s and 
1990s.
Some of these concerns are mirrored in the case of Bloomberg Philanthropies (BP), 
but not all. As Mayor of New York, Bloomberg, an ex-smoker, oversaw some radical 
tobacco control policies in the city. Combined with a hatred of the tobacco industry, 
he was persuaded by his tobacco control adviser Tom Frieden to put his considerable 
wealth behind the global effort to reduce death and disease from smoking.
Once the FCTC entered into force in 2005, Parties began implementation, but there 
was no money for the sort of data collection and monitoring required to determine 
progress in delivering the ambitions of the FCTC.
Bloomberg made no secret of the fact that he had little belief in the UN and its 
agencies to deliver anything within any reasonable time frame. In a parallel exercise to 
the FCTC Secretariat, which was collecting its own data from Parties, the now-renamed 
Bloomberg Initiative produced the MPOWER monitoring strategy. 
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61 Knowledge-Action-Change. Burning Issues: Global State of Tobacco Harm Reduction 2020. KAC, 2020, p.100.
62 Ibid.
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WHO TFI staff were unhappy with the high-handed approach taken by Bloomberg 
Philanthropies in trying to dictate to TFI staff on how to go about implementing 
MPOWER. But their appeals to the WHO Director-General fell on deaf ears. Staff were 
told just to take the money and get on with it – because there were no funds from 
anywhere else. Money that Bloomberg offered to the FCTC Secretariat was rejected, 
not on any ethical grounds, but more to underline the apparent animosity between the 
heads of the TFI and the FCTC Secretariat at the time.
Original image removed under threat of legal action from Bloomberg Philanthropies lawyers. View the original image here
https://twitter.com/who/status/1356948447077814274
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Since then, Bloomberg Philanthropies has funnelled around one billion dollars through 
a network of grantees headed up by CTFK and The Union. Because of the opacity of 
the funding streams, it is impossible to determine what percentage is devoted to anti-
THR activities. But given the degree of coordination between the WHO TFI and all the 
other Bloomberg Philanthropies grantees around attacking THR in many and various 
ways, it is reasonable to assume that this is a prime directive of the funding.  To show 
how closely the WHO is tied to Bloomberg Philanthropies, Michael Bloomberg is now 
the WHO Global Ambassador for Non-Communicable Diseases.
Several problems accrue from the money stream flowing from Bloomberg 
Philanthropies:
1.  Bloomberg Philanthropies monies are being used to conduct a war against nicotine 
and THR which is diametrically opposed to the best interests of global public health.
2.  Bloomberg Philanthropies monies are primarily targeted at LMIC. These countries 
are home to the most smokers and the highest rates of mortality and morbidity from 
smoking and are places where THR policies could be most effective.
3.  There are no obvious material benefits accruing to Bloomberg business interests 
from successful tobacco control policies in LMIC. This makes it more a case of 
philanthro-colonialism. Millions of dollars are being siphoned through boots-on-the-
ground grantees to interfere in the domestic tobacco control policies of sovereign 
nations. 
4.  The ‘corporate style’ expectations Bloomberg Philanthropies has of its grantees 
are where the philanthro-capitalism comes in. For-profit corporations operate 
on the basis of short-term planning cycles. The worlds of business, finance and 
consumerism move at pace. Bloomberg Philanthropies’ audit culture expects quick 
wins; in the world of tobacco control, that means getting laws and regulations onto 
the statute book with no thought given to longer-term evaluation. There certainly 
seems to be no thought given to the much more expensive and complicated 
business of establishing effective and accessible cessation services.
5.  All the smoke and mirrors of well-funded and highly organised global activity - 
primarily aimed at smoking prevention among young people - hides the unpalatable 
truth. Efforts to tackle the smoking epidemic are failing in LMIC and even stalling in 
HIC, as the falls in smoking prevalence begin to plateau.
Apart from western NGOs exerting pressure in LMIC against THR, these NGOs and 
WHO officials are in lockstep in exerting undue influence over information streams to 
FCTC Parties. It is the duty of the Parties to the FCTC to exercise the control they have 
and move the tobacco control agenda forward, and to recognise the potential of SNP 
to realise the ambitions of the FCTC.
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A moral imperative to act
The evidence in favour of embracing THR and SNP as valid public health interventions 
can no longer be seriously denied. To add to the growing body of evidence from 
independent expert groups, no fewer than fifteen past presidents of the Society for 
Research on Nicotine and Tobacco wrote a paper for the American Journal of Public 
Health in August 2021 in which they said,
“Because evidence indicates that e-cigarette use can increase the odds of 
quitting smoking, many scientists, including this essay’s authors, encourage the 
health community, media and policymakers to more carefully weigh vaping’s 
potential to reduce adult smoking-attributable mortality.”63
It is now a moral imperative that the WHO and allies retrench from their current 
intransigent and obstructive position of not only refusing to accept any positive health 
benefits from SNP, but actively campaigning against their use.
The FCTC is failing to adapt to the new reality for SNP because it is anti-THR elements 
within WHO and elsewhere who are calling the shots. They are failing to recognise the 
growing demand for these products across the world by smokers who want to switch 
away from the deadliest way of consuming nicotine.
Moving towards tobacco harm reduction
Parties should now be pressing for more evidence-based discussions on THR and SNP, 
calling upon the widest breadth of scientific, clinical and epidemiological expertise 
alongside those involved in the SNP industry, and taking into account the lived 
experience of consumers. Those Parties that have successfully introduced tobacco 
harm reduction policies alongside their tobacco control regimes – countries such 
as the United Kingdom and New Zealand – should be encouraged to lead the way, 
sharing evidence and best practice from their national perspectives. They need to 
prepare now so that THR is on the agenda for COP10 in 2023. It is up to Parties to 
propose this, as they determine the agenda, not the WHO or the Secretariat.
One pragmatic route forward could be the establishment of a Working Group on 
Tobacco Harm Reduction to take the FCTC forward into the 21st century in a world 
where SNP are now available. Modification of international conventions is difficult to 
achieve – and in reality, many of the problems with the FCTC are due to interpretation 
and implementation, including the neglect of harm reduction despite it being prominent 
in the FCTC text. A Working Group to elaborate on tobacco harm reduction could 
approach the FCTC with a new perspective, in which safer nicotine products have a 
role to play in bringing an end to smoking, and with a renewed focus on delivering 
tangible outcomes that reduce death and disease from smoking. The Working Group 
would need to develop interpretation and guidance which: 
1.  Disaggregates combustible and more dangerous oral tobacco products from safer 
non-combustible products as a key starting point. All FCTC Articles would need to 
it is anti-tobacco harm 
reduction elements 
within WhO who are 
calling the shots
63 Balfour, D et al. (2021) Balancing the risks and benefits of e-cigarettes. American Journal of Public Health https://ajph.
aphapublications.org/doi/abs/10.2105/AJPH.2021.306416
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be examined against this criteria. The FCTC text was adopted before SNP became 
widely available, and therefore needs reassessing in light of their emergence 
onto the market. The FCTC itself is clear in the Preamble that tobacco control 
policies must be based on “current and relevant scientific, technical and economic 
considerations”.
2.  Ensures the FCTC retrenches from mission creep, and reiterates that alongside 
supply and demand reduction, one of the first principles of the FCTC is to ‘reduce 
harm’ from tobacco smoke.
3.  Offers a clear definition of harm reduction within the FCTC, as the WHO sets out, 
for example, a definition as it relates to drugs and HIV: “Harm reduction is a set 
of policies, programmes, services and actions that aim to reduce the harm to 
individuals, communities and society related to drugs, including HIV infection. Harm 
reduction is key in the prevention of HIV infection among people who inject drugs 
(PWIDs) and their sexual partners.”65
4.  Ensures that, in line with long-standing international health and human rights 
treaties, representatives of all affected communities, including smokers and users of 
safer nicotine products, are recognised as legitimate stakeholders for the purposes 
of national and international policy deliberations.
5.  Calls for an end to an over-interpretation of the Guidelines of Article 5.3 which is 
currently not only preventing alternate views on tobacco control to be heard, but 
also shutting down the COP from legitimate public scrutiny.
‘Nothing about us without us’ is an important concept for tobacco harm reduction. 
Image: Google
64 WHO Regional Office For Europe, Policy guidance by HIV intervention area: harm reduction https://www.euro.who.int/en/
health-topics/communicable-diseases/hivaids/policy/policy-guidance-for-areas-of-intervention/harm-reduction
456: What can be done? New thinking for the 21st century
From MPOWER to EMPOWERED
Further to this, the Working Group could also highlight that it is the duty of the WHO to 
ensure that all smokers can access accurate information about the potential benefits 
of SNP, to ensure they can make informed choices. The WHO TFI should reframe 
MPOWER to EMPOWERED:
A start with community engagement would be to involve a wider range of civil society 
representation at COP and other meetings – primarily those with lived experience of 
making the switch from smoking to the use of SNP. As the Global State of Tobacco 
Harm Reduction estimated in 2020, there are now 100 million SNP users globally65 
whose voices are unheard in the tobacco and nicotine policymaking which affects their 
lives.
 
65 Burning Issues: The Global State of Tobacco Harm Reduction 2020. Knowledge-Action-Change, 2020, p.54 
https://gsthr.org/report/2020/burning-issues/chapter-2#unrialisedpublichealth 
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Despite the enactment of the FCTC and the accompanying MPOWER monitoring 
and evaluation tool, the projected death toll from smoking has remained unchanged 
for a decade. Over that period, new and disruptive technologies have produced 
demonstrably safer ways to consume nicotine while recent research has established 
the relative safety of an oral product called snus. Proof of concept has been 
established and the consumer market in safer nicotine products has grown to nearly 
100 million people.
However, instead of embracing and adapting to the new reality, the strategy of the 
WHO, its allies and key private funder is to continue to fight the old war against the 
tobacco industry. In doing so, they stand accused of deploying the same tactics as their 
sworn enemy, the tobacco industry - of sowing confusion and doubt about the safety 
and efficacy of SNP through misinformation and interference. There is little evidence 
of any concern for the welfare of current adult smokers; instead, the emphasis is on 
politically acceptable youth prevention strategies.
Evidence in favour of THR and SNP as a complementary intervention to help drive 
down death and disease from smoking is robust. It is robust enough for the Parties to 
the FCTC to take back control of the Convention and examine alternative policies to 
those advocated by the WHO, that all products should be banned or heavily regulated. 
The most important aspect of this policy and legislative review is to disaggregate 
combustible from non-combustible products. To that end, all relevant stakeholders 
need to be involved, including both the industry (in all its forms) and those consumers 
with lived experience of switching to SNP. National governments need to engage more 
readily with consumers so that they can effectively represent them at the COP. 
The imperative for international tobacco control policy in the 21st century is to preside 
over the dying embers of combustion. It must not use a new fight against nicotine to 
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Fighting the Last War:
The WHO and International Tobacco Control 
You can watch videos of the presentations from the report launch, held 
on 27 October 2021, at https://gsthr.org/events/ftlw/
Topic 
Welcome to the day and introduction  
to the session
‘From Hope to Despair – Tobacco control  
loses its way’
‘The origins and decline of the FCTC’ 




Introduction to the session 
‘Under the influence: The politics of 
international drug control’  
From Tobacco Control to HR advocacy:  
A Professional and  Personal Journey  
‘What have we learnt and what next for 
tobacco harm reduction’
 
Q&A session and concluding remarks 
Panellists
Will Godfrey (Session host)
Editor-in-chief of the Filter Magazine, USA 
Harry Shapiro
The author of the report K•A•C, UK
Derek Yach
Executive Director of the Foundation for a 
Smoke-Free World, USA
Tom Gleeson
New Nicotine Alliance Ireland
Panellists
Jeannie Cameron (Session host)
JCIC International, UK
Ethan Nadelmann 
Founder and former-Executive Director of the 





SESSION 1 – FCTC  Past, present and future
SESSION 2 – Challenges in making the FCTC an inclusive 
international framework convention
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